MTSR
Metsera Inc

545
Loading...
Loading...
News
all
press releases
Can PFE Successfully Return to the Obesity Space With Metsera Buyout?
Pfizer strikes a $4.9B deal for Metsera, adding obesity drug candidates to its pipeline after scrapping danuglipron.
Zacks·8d ago
News Placeholder
More News
News Placeholder
Company News for Sep 23, 2025
Companies In The News Are: ORCL, TAP, AAPL, MTSR, PFE.
Zacks·8d ago
News Placeholder
Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’
BTIG said Pfizer’s $7.3 billion Metsera acquisition sharpens its clinical updates and strategic optionality.
Stocktwits·8d ago
News Placeholder
Nvidia, Metsera, Oracle, Apple, Compass: Stocks Making The Biggest Moves Today
Nvidia’s shares were up nearly 4% in Monday’s afternoon session, hitting an all-time high, after the company announced that it will invest up to $100 billion in OpenAI as part of a new partnership with the AI startup.
Stocktwits·9d ago
News Placeholder
Metsera Stock Surges 59% Pre-Market After Pfizer Confirms Acquisition – Here Are The Details
The upfront purchase price of $47.50 per share implies a premium of 43% from Metsera’s closing share price on Friday.
Stocktwits·9d ago
News Placeholder
Pfizer Stock Draws Focus On Report Of $7.3B Deal Plan For Metsera Buyout As Obesity Drug Race With Lilly, Novo Heats Up
Pfizer is pushing into the booming weight-loss market after its own drug setback, as rivals Eli Lilly and Novo Nordisk lead the field.
Stocktwits·9d ago
News Placeholder
Recent Price Trend in Metsera Inc. (MTSR) is Your Friend, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Metsera Inc. (MTSR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Zacks·2mo ago
News Placeholder
Wall Street Analysts See a 55.72% Upside in Metsera Inc. (MTSR): Can the Stock Really Move This High?
The mean of analysts' price targets for Metsera Inc. (MTSR) points to a 55.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·3mo ago
News Placeholder
Metsera Inc. (MTSR) Is a Great Choice for 'Trend' Investors, Here's Why
Metsera Inc. (MTSR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Zacks·3mo ago
News Placeholder
Wall Street Analysts See an 89.66% Upside in Metsera Inc. (MTSR): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 89.7% in Metsera Inc. (MTSR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·3mo ago

Latest MTSR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.